Clinical trial
Dose Escalation of Sorafenib in Patients With Advanced Hepatocellular Carcinoma…
NCT00490685 · Istituto Clinico Humanitas, Other · Completed
Key facts
| NCT number | NCT00490685 |
|---|---|
| Title | Dose Escalation of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) |
| Official title | Randomized Continuation, Dose Escalation Trial of Sorafenib in Patients With Advanced HCC With Radiological Progression on Prior Sorafenib Treatment (Phase II Study) |
| Lead sponsor | Istituto Clinico Humanitas, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Hepatocellular |
| Intervention type | Drug |
| Interventions | Sorafenib (BAY-43-9006) |
| Enrollment | 142 |
| Start date | Apr 1, 2007 |
| Primary completion | Jun 1, 2008 |
| First posted | Jun 25, 2007 |
| Last update posted | Sep 2, 2010 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: